BRII-179
BRII-179-835-002
Phase 2 mab active
Quick answer
BRII-179 for For Treatment of Chronic Hepatitis B Virus Infection is a Phase 2 program (mab) at Vir Biotechnology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vir Biotechnology
- Indication
- For Treatment of Chronic Hepatitis B Virus Infection
- Phase
- Phase 2
- Modality
- mab
- Status
- active